GW&K Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

GW&K Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-683,702	Closed	-$35.3M	–	507
2022 Q3	$35.3M	Sell	683,702 -853,175	-56%	-$35.3M	0.39%	113
2022 Q2	$38.1M	Buy	1,536,877 +375,530	+32%	+$8.28M	0.41%	103
2022 Q1	$29.1M	Buy	1,161,347 +509,151	+78%	+$14.3M	0.26%	162
2021 Q4	$23.7M	Buy	+652,196	New	+$22.9M	0.2%	181

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GW&K Investment Management's CCXI Position: Q4 2022 in Review

GW&K Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 683,702 shares — an estimated $35.3M sold.

GW&K Investment Management first reported a position in CCXI in Q4 2021 and held it in 4 quarters. The position peaked at $38.1M in Q2 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

GW&K Investment Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
GW&K Investment Management sold 683,702 ChemoCentryx, Inc. shares in Q4 2022, an estimated $35.3M.
GW&K Investment Management first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 4 quarters.
GW&K Investment Management's ChemoCentryx, Inc. position peaked at $38.1M in Q2 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on GW&K Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.